- ￥1280 - 9776
- AntibodySystem
- France
- YVV33801
- 2025年12月06日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃
- 保质期：
12 months
- 英文名：
Recombinant Influenza D virus (Flu D) HE Protein, C-His
- 供应商：
武汉益普生物科技有限公司
- 规格：
50μg/100μg/1mg
| 规格： | 50μg | 产品价格： | ￥1280.0 |
|---|---|---|---|
| 规格： | 100μg | 产品价格： | ￥1880.0 |
| 规格： | 1mg | 产品价格： | ￥9776.0 |
| 产品名 | Recombinant Influenza D virus (Flu D) HE Protein, C-His |
| 货号 | YVV33801 |
| 别名 | Hemagglutinin-esterase-fusion glycoprotein, 3.1.1.53, HE |
| 表达系统 | E. coli |
| Accession号 | A0A088CKZ5 |
| 种属 | Influenza D virus (D/bovine/Shandong/Y217/2014) |
| 蛋白长度 | Asp80-Tyr400 |
| 预测分子量 | 36.20 kDa |
| 性质 | Recombinant |
| 内毒素水平 | Please contact with the lab for this information. |
| 纯度 | >90% as determined by SDS-PAGE. |
| 应用 | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| 状态 | Lyophilized |
| 保存溶液 | Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
| 运输 | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 说明 | For research use only. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验are not as important, as you are looking for a relatively small number of differences and so can devote more time to the identification of each protein.2D electrophoresis is performed in two steps(1) Isoelectric focusing (IEF) (First dimension electrophoresis): is used
are not as important, as you are looking for a relatively small number of differences and so can devote more time to the identification of each protein.2D electrophoresis is performed in two steps(1) Isoelectric focusing (IEF) (First dimension electrophoresis
The discovery of hepatitis B virus (HBV) four decades ago initiated the progressive increase in knowledge of an important hepatotropic infectious agent that culminated in the design of the first successful recombinant vaccine for a human
技术资料暂无技术资料 索取技术资料
